Enrofloxacin & Silver Sulfadiazine
30 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
30
Total Reports
4
Deaths Reported
1330.0%
Death Rate
Active Ingredients
Enrofloxacin & Silver Sulfadiazine
Administration Routes
Auricular (Otic)UnknownTopical
Species Affected
Dog 22
Cat 8
Most Affected Breeds
Retriever - Labrador 6
Domestic Shorthair 5
Bulldog 3
Shih Tzu 3
Terrier (unspecified) 2
Terrier - Yorkshire 2
Griffon - Brussels 1
Maine Coon 1
Hound - Basset 1
Persian 1
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 8
Other abnormal test result NOS 5
Abnormal radiograph finding 5
Anaemia NOS 4
Vomiting 4
Death by euthanasia 4
Neutrophilia 3
Anorexia 3
Shock 3
Abdominal cavity haemorrhage 3
Splenic neoplasm 3
Facial swelling (see also 'Skin') 3
Outcome Breakdown
Ongoing
18 (60.0%)
Recovered/Normal
5 (16.7%)
Euthanized
4 (13.3%)
Outcome Unknown
3 (10.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.